Menu Search
Equities

Bonzun AB (publ )

BONZUN:STO

Bonzun AB (publ )

Actions
  • Price (SEK)0.0448
  • Today's Change0.018 / 67.16%
  • Shares traded70.97m
  • 1 Year change-35.48%
  • Beta0.8146
Data delayed at least 15 minutes, as of May 03 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bonzun AB (publ ), formerly Papilly publ AB, is a Sweden-based company, which provides Internet-based healthcare services. Its offering application, which helps users to has a better control over their life, health and wellbeing. The Companys main products are: Bonzun IVF is a personalized and complete IVF app, its smart tools and emotional support to increase chances to succeed with ART treatments IVF, ICSI or Frozen Embryo Transfer (FET); Bonzun evolve helps companies and their employees to develop and strengthen their self-leadership and coping mechanisms to deal with stressful situations in the work environment and Kou Dai Yun Yu app, the virtual midwife, helps pregnant women understand when it is time to seek a doctor and when it is safe to stay home.

  • Revenue in SEK (TTM)4.17m
  • Net income in SEK-18.11m
  • Incorporated2012
  • Employees--
  • Location
    Bonzun AB (publ )Grev Turegatan 30STOCKHOLM 114 38SwedenSWE
  • Phone+46 86115100
  • Websitehttps://bonzun.com/
More ▼

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
FCG Fonder ABas of 30 Jun 20222.35k0.00%
Data from 31 Oct 2023 - 31 Oct 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.